Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells.
about
Preservative toxicity in glaucoma medication: clinical evaluation of benzalkonium chloride-free 0.5% timolol eye dropsCytoprotective effect of lacritin on human corneal epithelial cells exposed to benzalkonium chloride in vitroEffects of benzalkonium chloride on THP-1 differentiated macrophages in vitro.Efficacy, safety, and tolerability of travoprost 0.004% BAK-free versus prior treatment with latanoprost 0.005% in Japanese patientsDetermining the Depth of Injury in Bioengineered Tissue Models of Cornea and Conjunctiva for the Prediction of All Three Ocular GHS Categories.Semaphorin 3A controls allergic and inflammatory responses in experimental allergic conjunctivitis.Ocular tropism of influenza A viruses: identification of H7 subtype-specific host responses in human respiratory and ocular cells.Challenges in the clinical measurement of ocular surface disease in glaucoma patients.Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.Comparison of the Efficacy of Fluorometholone With and Without Benzalkonium Chloride in Ocular Surface Disease.In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis).Effect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma.Bimatoprost 0.01% vs bimatoprost 0.03%: a 12-month prospective trial of clinical and in vivo confocal microscopy in glaucoma patientsA Comparison of the Effects of Benzalkonium Chloride on Ocular Surfaces between C57BL/6 and BALB/c Mice.Ophthalmic preservatives: focus on polyquaternium-1.Preliminary studies on validation of calu-3 cell line as a model for screening respiratory mucosa irritation and toxicity.Increased extracellular matrix metalloproteinase inducer (EMMPRIN) expression in the conjunctival epithelium exposed to antiglaucoma treatments.Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits.CX3CL1 expression in the conjunctiva is involved in immune cell trafficking during toxic ocular surface inflammation.Patient adherence and persistence with topical ocular hypotensive therapy in real-world practice: a comparison of bimatoprost 0.01% and travoprost Z 0.004% ophthalmic solutions.Aqueous humor penetration of topical bimatoprost 0.01% and bimatoprost 0.03% in rabbits.Analysis of the effects of preservative-free tafluprost on the tear proteome.Balancing antimicrobial efficacy and toxicity of currently available topical ophthalmic preservatives.In vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma.Ex vivo corneal epithelial wound healing following exposure to ophthalmic nonsteroidal anti-inflammatory drugs.Effects of timolol-related ophthalmic solutions on cultured human conjunctival cells.In vitro effects of preserved and unpreserved anti-allergic drugs on human corneal epithelial cells.Human corneal epithelial cell shedding and fluorescein staining in response to silicone hydrogel lenses and contact lens disinfecting solutions.Effects of ophthalmic disease on concentrations of plasma fibrinogen and serum amyloid A in the horse.
P2860
Q27009083-ADD04936-8B43-42EA-9DEF-0767D03085AAQ30389442-4A9B99D4-043D-459C-B77E-110943550444Q31132977-DE6834C5-E19E-4BCA-AC48-2B9AE24388FAQ34393007-58D0ECF9-F27F-40C8-B038-9C7A6D71D760Q34672610-6BD5BD0B-5A11-46E2-A8AB-F0DEC6BE130EQ35075328-D4ED4CA1-47EB-4B49-888A-05EC53951D16Q35382551-0E93684D-7A33-45A3-B7C5-B90F5D5DD6B0Q35555771-6E216CA4-BC3A-4334-B6DA-CBA053629335Q36099684-52FC3F72-9545-4C0A-BA93-A11A05DDCCCCQ36240200-30389B95-5C1B-4F33-8C96-3C49575556FAQ36443965-8A534688-C2B3-43F8-9666-5748E30E6848Q36898923-B7BC3622-1585-4787-94B6-3AA4F6608737Q36908446-01E17FAE-9C5D-4BB1-9DD5-381FD5D652CCQ37697869-FFACD635-C5F5-40F0-BE42-8D6CB0799374Q37729041-FD0D2340-4661-4096-8CC9-6719A9436B3BQ37929746-4035D52D-09AB-41D1-8C27-8CDE8229027EQ38981502-5C4F8296-28C8-441F-8845-16F217D368ABQ38994594-86290959-A2A2-4476-9B7D-0F4C6AF80185Q39221538-FE1DF597-E36B-49FA-B8B6-D8C324459ED0Q39332349-846DC6C5-CFC8-480B-85CD-C89F783E6D01Q39791012-23819EAE-443A-44E8-86DA-3EA9C6239B32Q41125727-3A259C45-06CB-4C10-8FCD-D3B20533519AQ41668980-BFF8AC95-C256-4029-943B-B9FCCC2B99CAQ41717624-C82FB933-1409-464E-95E6-82E2DEA13ED4Q42617474-574F394F-F1E9-4BEA-AC58-02B67874F101Q42704847-B148EE48-7C43-4B26-9692-0AF7B6F77C44Q42769999-4BAF3ACE-B047-430B-AC01-21C231ABC3D3Q42975877-DB3342B9-E3FB-4138-A75D-D77CD00F405AQ44666122-3ED5B3FE-C796-440F-B9C8-B612D0DBCB17Q48270719-8E2733B2-5005-4E86-BA06-BD7BBCD50E71
P2860
Evaluation of biomarkers of inflammation in response to benzalkonium chloride on corneal and conjunctival epithelial cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Evaluation of biomarkers of in ...... conjunctival epithelial cells.
@ast
Evaluation of biomarkers of in ...... conjunctival epithelial cells.
@en
Evaluation of biomarkers of in ...... conjunctival epithelial cells.
@nl
type
label
Evaluation of biomarkers of in ...... conjunctival epithelial cells.
@ast
Evaluation of biomarkers of in ...... conjunctival epithelial cells.
@en
Evaluation of biomarkers of in ...... conjunctival epithelial cells.
@nl
prefLabel
Evaluation of biomarkers of in ...... conjunctival epithelial cells.
@ast
Evaluation of biomarkers of in ...... conjunctival epithelial cells.
@en
Evaluation of biomarkers of in ...... conjunctival epithelial cells.
@nl
P2860
P356
P1476
Evaluation of biomarkers of in ...... conjunctival epithelial cells.
@en
P2093
Dongmei Chen
Seth P Epstein
P2860
P304
P356
10.1089/JOP.2008.0140
P50
P577
2009-10-01T00:00:00Z